Short answer
Xenon Pharmaceuticals Inc. (XENE) filed an 8-K current report with the SEC on March 13, 2026 reporting Item 8.01 (Other Events). Annual meeting details filed with Canadian SEDAR system on March 13, 2026.
Xenon Pharmaceuticals Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Annual meeting details filed with Canadian SEDAR system on March 13, 2026
- Disclosure reflects dual-reporting obligations as a Canadian-incorporated, Nasdaq-listed company
- Investors should monitor SEDAR filing for record date, meeting date, and shareholder vote agenda items
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Xenon Pharmaceuticals Inc. 8-K filings
Get the next XENE 8-K as it lands
Follow XENE for push alerts, or ask the research agent what this filing means.